Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.630 -0.070 (-1.49%)

Streaming Delayed Price Updated: 3:43 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

2 Healthcare AI Stocks That Could Go Parabolic ↗

August 02, 2023

Shares of Recursion Pharmaceuticals and GE Healthcare are both up sharply so far this year.

Via The Motley Fool

Recursion to Participate in Upcoming Investor Conference

August 01, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist

August 01, 2023

Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.

Via MarketBeat

Topics Artificial Intelligence

These 10 AI Stocks Are Up An Average Of 99% In Last 3 Months ↗

July 30, 2023

Ten artificial intelligence and AI-related (AI&R) stocks, with market capitalizations of +$1.5B, have advanced by 70% or more (average of 99%!) since the bubble began to develop at the end of April....

Via Talk Markets

Where Recursion Pharmaceuticals Stands With Analysts ↗

July 13, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

July 28, 2023

Via Benzinga

Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential

July 28, 2023

A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.

Via MarketBeat

Topics Artificial Intelligence

Exscientia is the Sniper of the AI Drug Discovery Industry

July 27, 2023

News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion

Via MarketBeat

Topics Artificial Intelligence

Nvidia’s AI Explosion: What NVDA Stock Investors Need to Know Now ↗

July 27, 2023

Rather than sell your Nvidia shares, diversify. That's what the Cloud Czars want to do. They'll save, and you'll profit.

Via InvestorPlace

Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships

July 26, 2023

Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic...

From Recursion Pharmaceuticals

Via GlobeNewswire

These 26 AI Stocks Are Up 58% In Just 11 Weeks ↗

July 24, 2023

The Bank of America suggests that this is just a

Via Talk Markets

MarketBeat Week in Review – 7/17 - 7/21

July 22, 2023

Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks

Via MarketBeat

Topics Economy

3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other ↗

July 21, 2023

They're not guaranteed to keep soaring, but they are right now.

Via The Motley Fool

Did Nvidia Just Trigger a Short Squeeze in RXRX Stock? ↗

July 19, 2023

Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week.

Via InvestorPlace

AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday ↗

July 19, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why It May Not Be Too Late to Join Nvidia’s Sky-High AI Rally ↗

July 19, 2023

As long as Nvidia is a darling of the market - and as long as the company invests in future-facing technology - NVDA stock has room to run.

Via InvestorPlace

Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals ↗

July 18, 2023

Both companies could tap into huge growth from the AI revolution in a few years.

Via The Motley Fool

NVIDIA Just Invested $50 Million in This Biotech -- Should You Buy It? ↗

July 18, 2023

Gaining one of the world's most important AI companies as a collaborator is huge.

Via The Motley Fool

NVDA Stock Update: What Nvidia Investors Need to Be Watching Now ↗

July 18, 2023

With Nvidia still the best option for long-term investors looking to take advantage of the AI race, here's what to watch.

Via InvestorPlace

Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗

July 17, 2023

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

Via Talk Markets

Nvidia Invested $50 million into This AI Drug Discovery Biotech

July 17, 2023

Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from

Via MarketBeat

Topics Artificial Intelligence

3 Biotech Stocks Using AI to Change Healthcare Forever ↗

July 14, 2023

These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past.

Via InvestorPlace

Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About ↗

July 14, 2023

Investors are on the hunt for undervalued, under followed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information.

Via Benzinga

Why Recursion Pharmaceuticals Stock Is Skyrocketing This Week (Hint: Thanks, Nvidia) ↗

July 14, 2023

The small biotech is enjoying the rewards of being linked to one of the hottest AI giants around.

Via The Motley Fool

Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play? ↗

July 13, 2023

RXRX stock is the talk of Wall Street today after Recursion Pharmaceuticals shot up 100% on a new Nvidia investment.

Via InvestorPlace

Why Recursion Pharmaceuticals (RXRX) Stock Is Falling Thursday ↗

July 13, 2023

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) shares are trading lower on Thursday as traders appear to be taking profits. The stock rallied on Wednesday after the company announced a $50 m

Via Benzinga

July 12, 2023

Via Benzinga

Nvidia Just Invested in This Pharmaceutical Company, Causing Its Stock Price to Skyrocket ↗

July 12, 2023

Nvidia's investment in Recursion caused its stock price to jump dramatically on Tuesday.

Via The Motley Fool

RXRX Stock: Nvidia Investment Sends Recursion Pharmaceuticals Soaring ↗

July 12, 2023

Nvidia just invested millions into Recursion Pharmaceuticals, bolstering AI integration in biotech but also presenting risks for RXRX stock.

Via InvestorPlace

Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher ↗

July 12, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&P 500,...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.